Rufinamide 200 mg, 400 mg, 40 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Tablets / Oral suspension

Available Strengths: 200 mg, 400 mg, 40 mg/mL

Reference Brands: Banzel (USA)

Category: Neurology

Rufinamide is a Neurology product available as Tablets / Oral suspension in strengths 200 mg, 400 mg, 40 mg/mL. It corresponds to the reference brand Banzel (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Rufinamide is an anticonvulsant and antiepileptic medication primarily used as adjunctive therapy for the management of seizures associated with Lennox–Gastaut syndrome, a severe and rare form of epilepsy. It is approved for use in children aged four years and older as well as in adult patients. Rufinamide belongs to the triazole derivative class of antiepileptic drugs and exerts its therapeutic effect by modulating sodium channel activity in the brain, thereby helping to stabilize neuronal firing and reduce seizure frequency and severity.

The drug was developed in 2004 by Novartis Pharma AG and is commercially manufactured and marketed by Eisai. Rufinamide is officially approved by regulatory authorities such as the US FDA for Lennox–Gastaut syndrome; however, emerging clinical studies have indicated potential benefits in the treatment of partial seizures, although this indication is not included in its current FDA-approved labeling. Rufinamide is available in oral tablet and oral suspension dosage forms, allowing flexibility in dosing for pediatric and adult patients. It is marketed under the brand name Banzel in the United States and Inovelon in the European Union and the United Kingdom, with multiple generic versions available worldwide.